BRPI0412737A - sistema semi-sólidos contendo derivados de azetidina - Google Patents

sistema semi-sólidos contendo derivados de azetidina

Info

Publication number
BRPI0412737A
BRPI0412737A BRPI0412737-4A BRPI0412737A BRPI0412737A BR PI0412737 A BRPI0412737 A BR PI0412737A BR PI0412737 A BRPI0412737 A BR PI0412737A BR PI0412737 A BRPI0412737 A BR PI0412737A
Authority
BR
Brazil
Prior art keywords
semi
system containing
azetidine derivatives
solid system
containing azetidine
Prior art date
Application number
BRPI0412737-4A
Other languages
English (en)
Inventor
Maria-Teresa Peracchia
Sophie Cote
Valerie Bobineau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BRPI0412737A publication Critical patent/BRPI0412737A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"SISTEMAS SEMI-SóLIDOS CONTENDO DERIVADOS DE AZETIDINA". A presente invenção refere-se a novas formulações de derivados de azetidina para administração oral.
BRPI0412737-4A 2003-07-18 2004-07-08 sistema semi-sólidos contendo derivados de azetidina BRPI0412737A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291796A EP1498122A1 (en) 2003-07-18 2003-07-18 Semi-solid systems containing azetidine derivatives
PCT/EP2004/008553 WO2005013973A1 (en) 2003-07-18 2004-07-08 Semi-solid systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
BRPI0412737A true BRPI0412737A (pt) 2006-09-26

Family

ID=33462259

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412737-4A BRPI0412737A (pt) 2003-07-18 2004-07-08 sistema semi-sólidos contendo derivados de azetidina

Country Status (30)

Country Link
US (2) US20050026898A1 (pt)
EP (2) EP1498122A1 (pt)
JP (1) JP2009513560A (pt)
KR (1) KR20060040691A (pt)
CN (1) CN1822831A (pt)
AR (1) AR045997A1 (pt)
AU (1) AU2004262498B2 (pt)
BR (1) BRPI0412737A (pt)
CA (1) CA2532669A1 (pt)
CR (1) CR8179A (pt)
EC (1) ECSP066292A (pt)
GT (1) GT200400135A (pt)
HR (1) HRP20060022A2 (pt)
IL (1) IL173111A0 (pt)
MA (1) MA27922A1 (pt)
MX (1) MXPA06000483A (pt)
MY (1) MY142077A (pt)
NO (1) NO20060509L (pt)
OA (1) OA13191A (pt)
PA (1) PA8606701A1 (pt)
PE (1) PE20050287A1 (pt)
RS (1) RS20060016A (pt)
RU (1) RU2343915C2 (pt)
SG (1) SG144141A1 (pt)
TN (1) TNSN06013A1 (pt)
TW (1) TW200522945A (pt)
UA (1) UA80633C2 (pt)
UY (1) UY28421A1 (pt)
WO (1) WO2005013973A1 (pt)
ZA (1) ZA200600490B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005309808A1 (en) * 2004-11-24 2006-06-01 Merck & Co., Inc. Liquid and semi-solid pharmaceutical formulations for oral administration of a substituted amide
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
EP2637655B1 (en) * 2010-11-08 2019-01-09 Cadila Pharmaceuticals Ltd. Pharmaceutical composition of taxoids
CN105848643A (zh) * 2013-12-23 2016-08-10 强生消费者公司 消旋卡多曲组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0825849A1 (en) * 1995-05-19 1998-03-04 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
US6281243B1 (en) * 1998-02-26 2001-08-28 Akzo Nobel N.V. Derivatives of azetidine and pyrrolidine
JP2002520377A (ja) * 1998-07-14 2002-07-09 イーエム インダストリーズ インコーポレイテッド ミクロ分散薬物送達システム
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives

Also Published As

Publication number Publication date
US20080293686A1 (en) 2008-11-27
AR045997A1 (es) 2005-11-23
MA27922A1 (fr) 2006-06-01
TNSN06013A1 (en) 2007-10-03
ZA200600490B (en) 2007-05-30
OA13191A (en) 2006-12-13
TW200522945A (en) 2005-07-16
JP2009513560A (ja) 2009-04-02
RU2343915C2 (ru) 2009-01-20
AU2004262498A2 (en) 2005-02-17
ECSP066292A (es) 2006-10-25
PA8606701A1 (es) 2005-02-04
CR8179A (es) 2006-09-22
KR20060040691A (ko) 2006-05-10
CN1822831A (zh) 2006-08-23
EP1648442A1 (en) 2006-04-26
AU2004262498A1 (en) 2005-02-17
UA80633C2 (en) 2007-10-10
MXPA06000483A (es) 2006-04-05
SG144141A1 (en) 2008-07-29
PE20050287A1 (es) 2005-06-13
IL173111A0 (en) 2006-06-11
EP1498122A1 (en) 2005-01-19
WO2005013973A1 (en) 2005-02-17
US20050026898A1 (en) 2005-02-03
MY142077A (en) 2010-08-30
RU2006105011A (ru) 2006-06-10
HRP20060022A2 (en) 2006-02-28
NO20060509L (no) 2006-01-31
AU2004262498B2 (en) 2009-01-22
RS20060016A (en) 2008-06-05
UY28421A1 (es) 2005-02-28
CA2532669A1 (en) 2005-02-17
GT200400135A (es) 2005-08-25

Similar Documents

Publication Publication Date Title
CO5590918A2 (es) Formulaciones
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
PA8595901A1 (es) "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NO20053150D0 (no) System for administrasjon av medisin.
BRPI0414864A (pt) composição farmacêutica multiparticulada compreendendo ácido micofenólico ou micofenolato de sódio e combinação com rapamicida
ES2176296T3 (es) Composiciones farmaceuticas que permiten la liberacion prolongada de trimetacidina despues de la administracion por via oral.
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
BRPI0412239A (pt) sistemas emulsificantes contendo derivados de azetidina
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
NO20064808L (no) Orale matrixformuleringer med licarbazepin
UY28421A1 (es) Sistemas semi-sólidos que contienen derivados de azetidina
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
FR2861992B1 (fr) Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
ITTO20020672A0 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
ITRM20020357A0 (it) Composizione liquida per la somministrazione orale di lorazepam.
HN2002000331A (es) Composiciones farmaceuticas de 5,7,14-triazatetra-ciclo (10.3.1.02,11.04,9)-hexadeca-2(11) 3,5,7,9-pentaeno

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.